April 2021 Comprehensive Economical Analysis Shows Screening Diabetic Patients for NAFLD is Cost Effective in the United States
April 2021 FibroScan® 630 Expert: Non-Invasive Assessment for Risk of Portal Hypertension Superior to Liver Biopsy
April 2021 Rise of Liver Cancer Rates and Link to Non-alcoholic Fatty Liver Disease Highlight Importance of Early Detection